Arrowhead Pharmaceuticals... (ARWR)
NASDAQ: ARWR
· Real-Time Price · USD
20.50
1.72 (9.16%)
At close: Aug 15, 2025, 3:59 PM
20.90
1.93%
After-hours: Aug 15, 2025, 07:44 PM EDT
Arrowhead Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 596.57M | 568.8M | 26.09M | 27.14M | 19.65M | 35.47M | 181.74M | 240.74M | 256.21M | 272.8M | 278.34M | 243.23M | 249.94M | 263.42M | 144.42M | 138.29M | 107.64M | 89.12M | 79.84M |
Cost of Revenue | 31.11M | 29.67M | 28.11M | 27.14M | 17.43M | 12.65M | 8.12M | 3.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 576.77M | 550.45M | 3.21M | 4.26M | 6.48M | 11.26M | 15.79M | 12.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -107.96M | -118.55M | -625.95M | -601.08M | -547.21M | -473.77M | -299.41M | -205M | -180.5M | -150.71M | -157.32M | -178.51M | -159.56M | -118.52M | -188.3M | -149.04M | -134.27M | -118.35M | -112.36M |
Interest Income | 35.41M | 30.89M | 27.52M | 22.72M | 19.43M | 17.11M | 15.42M | 15.3M | 13M | 10.06M | 6.56M | 5.03M | 3.45M | 2.21M | 1.16M | 2.17M | 2.17M | 2.17M | 2.17M |
Pretax Income | -153.97M | -152.27M | -648.89M | -612.46M | -548.65M | -478.06M | -303.39M | -206.49M | -179.66M | -148.32M | -151.63M | -172.71M | -153.92M | -111.8M | -182.99M | -140.85M | -125.9M | -109.59M | -102.61M |
Net Income | -148.42M | -143.97M | -639.71M | -599.49M | -538.64M | -470.79M | -296.81M | -205.28M | -181.11M | -150.21M | -154.52M | -176.06M | -153.93M | -111.8M | -182.99M | -140.85M | -125.91M | -109.59M | -102.61M |
Selling & General & Admin | 111.03M | 103.28M | 100.03M | 96.82M | 95.2M | 95.37M | 93.54M | 90.93M | 98.39M | 107.76M | 118.81M | 122.82M | 129.48M | 114.6M | 96.93M | 80.98M | 56.96M | 49.7M | 49.68M |
Research & Development | 568.3M | 558.36M | 526.38M | 505.87M | 469.9M | 412.23M | 385.98M | 353.19M | 336.71M | 314.13M | 315.24M | 297.31M | 279.7M | 266.84M | 235.55M | 206.34M | 184.06M | 157.31M | 142.06M |
Other Expenses | -4.61M | 2.12M | 2.04M | 1.94M | 1.75M | 1.65M | 1.63M | 1.62M | 1.62M | 1.61M | 1.61M | 1.61M | 323K | 497K | 249K | n/a | 887K | 464K | 461K |
Operating Expenses | 674.72M | 663.76M | 628.45M | 604.63M | 566.86M | 509.24M | 481.15M | 445.74M | 436.71M | 423.51M | 435.66M | 421.74M | 409.5M | 381.94M | 332.73M | 287.32M | 241.91M | 207.47M | 192.2M |
Interest Expense | 82.31M | 63.03M | 48.63M | 32.35M | 22.97M | 23.03M | 20.84M | 18.33M | 13.06M | 7.91M | 2.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 680.94M | 663.76M | 628.45M | 604.63M | 566.86M | 509.24M | 481.15M | 445.74M | 436.71M | 423.51M | 435.66M | 421.74M | 409.5M | 381.94M | 332.73M | 287.32M | 241.91M | 207.47M | 192.2M |
Income Tax Expense | 1.97M | 2.4M | 649K | -2.77M | -1.29M | -546K | -546K | 2.78M | 4.54M | 3.8M | 3.8M | 3.79M | 2K | 2K | 2K | 2K | 2.4K | 2.4K | 2.4K |
Shares Outstanding (Basic) | 139.04M | 133.36M | 124.85M | 121.99M | 124.2M | 123.28M | 107.42M | 107.31M | 107M | 106.76M | 106.04M | 105.75M | 105.75M | 105.55M | 104.53M | 104.27M | 103.19M | 103.15M | 102.76M |
Shares Outstanding (Diluted) | 139.04M | 134.48M | 124.85M | 121.99M | 124.2M | 123.28M | 107.42M | 107.31M | 107M | 108.14M | 106.04M | 105.75M | 105.75M | 107.93M | 104.53M | 104.53M | 104.1M | 103.87M | 102.76M |
EPS (Basic) | -1.27 | -1.39 | -5.19 | -5.04 | -4.66 | -4.24 | -2.76 | -1.91 | -1.7 | -1.41 | -1.45 | -1.66 | -1.46 | -1.08 | -1.76 | -1.36 | -1.22 | -1.06 | -1 |
EPS (Diluted) | -1.3 | -1.42 | -5.19 | -5.04 | -4.66 | -4.24 | -2.77 | -1.92 | -1.71 | -1.42 | -1.46 | -1.67 | -1.47 | -1.09 | -1.76 | -1.36 | -1.22 | -1.06 | -1 |
EBITDA | -69.57M | -68.12M | -580.69M | -561.51M | -508.26M | -439.1M | -268.48M | -175.67M | -156.97M | -131.48M | -139.92M | -164.41M | -145.62M | -106.04M | -179.31M | -140.77M | -126.74M | -111.27M | -105.83M |
EBIT | -75.07M | -89.25M | -600.25M | -580.11M | -525.68M | -455.03M | -282.54M | -188.16M | -168.27M | -142.09M | -150.46M | -174.83M | -155.88M | -115.71M | -188.3M | -149.04M | -134.27M | -118.35M | -112.36M |
Depreciation & Amortization | 22.57M | 21.13M | 19.57M | 18.59M | 17.43M | 15.92M | 14.07M | 12.49M | 11.29M | 10.61M | 10.54M | 10.42M | 10.27M | 9.67M | 8.99M | 8.27M | 7.54M | 7.08M | 6.53M |